Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSPB1 | P04792 | 3/20 | 0.56 |
| ▸ | MEN1 | O00255 | 4/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.52 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | LMNA | P02545 | 4/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | TBXA2R | P21731 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | MLNR | O43193 | 1/20 | 0.46 |
| ▸ | MMP1 | P03956 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7632959 | 0.87 | HSPB1 (0.66) | HSPB1MEN1KMT2ARXFP1HTT | |
| SCHEMBL1979596 | 0.87 | HSPB1 (0.53) | HSPB1MEN1KMT2ARXFP1HTT | |
| SCHEMBL5082634 | 0.83 | ALDH1A1 (0.66) | HSPB1MEN1KMT2ARXFP1HTT | |
| SCHEMBL9087468 | 0.82 | HSPB1 (0.59) | HSPB1MEN1KMT2ARXFP1HTT | |
| SCHEMBL22966296 | 0.81 | TBXA2R (0.56) | HSPB1MEN1KMT2AHTTSMN1; SMN2 | |
| SCHEMBL7690257 | 0.81 | ALDH1A1 (0.59) | MEN1KMT2AHTTSMN1; SMN2ALDH1A1 | |
| SCHEMBL28337651 | 0.81 | MEN1 (0.54) | HSPB1MEN1KMT2AHTTSMN1; SMN2 | |
| SCHEMBL6420032 | 0.81 | HSPB1 (0.68) | HSPB1MEN1KMT2AHTTSMN1; SMN2 | |
| SCHEMBL15869609 | 0.81 | MAPT (0.68) | MEN1KMT2AHTTSMN1; SMN2ALDH1A1 | |
| SCHEMBL31448160 | 0.81 | HSPB1 (0.53) | HSPB1MEN1KMT2ARXFP1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2065357-B1 | Improved process for the catalytic synthesis of diaryl ethers | SALTIGO GMBH (DE) | 2014-04-23 | — | — | EP | disclosed |
| US-8304550-B2 | Process for the catalytic synthesis of diaryl ethers | SALTIGO GMBH (DE) | 2012-11-06 | — | — | US | disclosed |
| US-8304550-B2 | Process for the catalytic synthesis of diaryl ethers | SALTIGO GMBH (DE) | 2012-11-06 | — | — | US | disclosed |
| WO-2009117421-A2 | HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE | KALYPSYS, INC. (US) | 2009-09-24 | — | — | WO | disclosed |
| US-20090143594-A1 | PROCESS FOR THE CATALYTIC SYNTHESIS OF DIARYL ETHERS | SALTIGO GMBH (DE) | 2009-06-04 | — | — | US | disclosed |
| US-20090143594-A1 | PROCESS FOR THE CATALYTIC SYNTHESIS OF DIARYL ETHERS | SALTIGO GMBH (DE) | 2009-06-04 | — | — | US | disclosed |
| EP-2065357-A1 | Improved process for the catalytic synthesis of diaryl ethers | Saltigo GmbH (DE) | 2009-06-03 | — | — | EP | disclosed |
| EP-2065356-A1 | Improved process for the catalytic synthesis of diaryl ethers | Saltigo GmbH (DE) | 2009-06-03 | — | — | EP | disclosed |
| US-5750789-A | FROM CORRESPONDING DIAMINE | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 1998-05-12 | — | — | US | disclosed |
| EP-0335274-B1 | Formation of nitrophenyl ethers from polyols and nitroanisoles | DOW CHEMICAL CO (US) | 1996-03-13 | — | — | EP | disclosed |
| US-5498687-A | Unsaturated imide compounds containing alicyclic structure, process for producing the same and intermediate therefor | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1996-03-12 | — | — | US | disclosed |
| US-5444165-A | Reacting diamino compound with unsaturated dicarboxylic anhydride to form amic acid intermediate, catalytic dehydration-ring closing; solvent soluble, low water absorption and flexibility | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1995-08-22 | — | — | US | disclosed |
| US-5326881-A | Polymers with good heat resistance, good flexibility and low water absorption | SUMITOMO CHEMICAL COMPANY LTD. (JP) | 1994-07-05 | — | — | US | disclosed |
| EP-0595230-A1 | Unsaturated imide compounds containing alicyclic structure | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1994-05-04 | — | — | EP | disclosed |
| US-4960950-A | Formation of nitrophenyl ethers from polyols and nitroanisoles | THE DOW CHEMICAL COMPANY (US) | 1990-10-02 | — | — | US | disclosed |
| EP-0335274-A2 | Formation of nitrophenyl ethers from polyols and nitroanisoles | THE DOW CHEMICAL COMPANY (US) | 1989-10-04 | — | — | EP | disclosed |
| US-4533777-A | HALOALKYLATION OF A BENZENE RING USING CARBON TETRACHLORIDE AND HYDROFLUORIC ACID | BAYER AKTIENGESELLSCHAFT (DE) | 1985-08-06 | — | — | US | disclosed |
| EP-0008453-B1 | PROCESS FOR PREPARING TRIFLUOROMETHYL AROMATIC COMPOUNDS | BAYER AG (DE) | 1981-04-29 | — | — | EP | disclosed |
| EP-0008453-A1 | Process for preparing trifluoromethyl aromatic compounds | BAYER AG (DE) | 1980-03-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090143594-A1 | PROCESS FOR THE CATALYTIC SYNTHESIS OF DIARYL ETHERS | ARSA, AHR, AOC2 | HSPB1 3379/4885MEN1 2795/4885KMT2A 426/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.